DekaBank Deutsche Girozentrale Grows Stock Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

DekaBank Deutsche Girozentrale increased its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 0.8% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 961,161 shares of the company's stock after buying an additional 7,369 shares during the period. DekaBank Deutsche Girozentrale owned about 0.78% of Henry Schein worth $65,205,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently added to or reduced their stakes in the company. Farther Finance Advisors LLC raised its position in Henry Schein by 237.3% during the first quarter. Farther Finance Advisors LLC now owns 2,698 shares of the company's stock worth $186,000 after acquiring an additional 1,898 shares during the last quarter. Charles Schwab Investment Management Inc. raised its position in Henry Schein by 1.4% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,191,677 shares of the company's stock worth $82,464,000 after acquiring an additional 16,616 shares during the last quarter. State of Alaska Department of Revenue raised its position in Henry Schein by 2.8% during the first quarter. State of Alaska Department of Revenue now owns 14,611 shares of the company's stock worth $1,000,000 after acquiring an additional 395 shares during the last quarter. Oppenheimer Asset Management Inc. raised its position in Henry Schein by 5.2% during the first quarter. Oppenheimer Asset Management Inc. now owns 13,745 shares of the company's stock worth $941,000 after acquiring an additional 678 shares during the last quarter. Finally, GAMMA Investing LLC raised its position in Henry Schein by 37.8% during the first quarter. GAMMA Investing LLC now owns 3,939 shares of the company's stock worth $270,000 after acquiring an additional 1,081 shares during the last quarter. Hedge funds and other institutional investors own 96.62% of the company's stock.

Henry Schein Trading Down 1.5%

Henry Schein stock traded down $1.11 during trading on Friday, reaching $73.42. The company had a trading volume of 1,446,652 shares, compared to its average volume of 1,727,684. Henry Schein, Inc. has a 12-month low of $60.56 and a 12-month high of $82.49. The stock's 50 day moving average price is $71.56 and its two-hundred day moving average price is $71.33. The firm has a market capitalization of $8.94 billion, a price-to-earnings ratio of 22.94, a PEG ratio of 2.37 and a beta of 0.87. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.75 and a current ratio of 1.38.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its earnings results on Monday, May 5th. The company reported $1.15 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.11 by $0.04. Henry Schein had a net margin of 3.21% and a return on equity of 14.87%. The firm had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.24 billion. During the same period in the previous year, the firm earned $1.10 earnings per share. Henry Schein's revenue was down .1% compared to the same quarter last year. As a group, equities analysts expect that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on HSIC shares. Wall Street Zen cut shares of Henry Schein from a "buy" rating to a "hold" rating in a research report on Thursday, April 17th. Wells Fargo & Company cut their price objective on shares of Henry Schein from $80.00 to $75.00 and set an "equal weight" rating for the company in a research report on Tuesday, May 6th. Piper Sandler cut their price objective on shares of Henry Schein from $83.00 to $77.00 and set an "overweight" rating for the company in a research report on Wednesday, April 30th. Evercore ISI boosted their price objective on shares of Henry Schein from $72.00 to $78.00 and gave the company an "in-line" rating in a research report on Wednesday. Finally, Barrington Research cut their price objective on shares of Henry Schein from $90.00 to $86.00 and set an "outperform" rating for the company in a research report on Tuesday, May 6th. Six analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $79.70.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.